Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma

Proto-oncogene tyrosine-protein kinase Src plays an important role in Head and Neck Squamous Cell Carcinoma (HNSCC). However, the FDA-approved SRC inhibitor Dasatinib shows very limited efficacy in HNSCC clinical trials, even though Dasatinib can completely inhibit SRC in the laboratory setting. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zejia, Liao, Jipei, Cullen, Kevin J., Dan, Hancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229171/
https://www.ncbi.nlm.nih.gov/pubmed/32435511
http://dx.doi.org/10.1038/s41420-020-0270-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229171/
https://www.ncbi.nlm.nih.gov/pubmed/32435511
http://dx.doi.org/10.1038/s41420-020-0270-7

Ejemplares similares